Brachytherapy is a radiotherapy technique in which radioactive devices are implanted near tumor sites to safely delivery high doses of radiation to eliminate and shrink malignant tumors while simultaneously preventing damage to surrounding tissues.
Rapidly rising global caseload of cancer, increasing use of brachytherapy in cancer management, and technological advancements in afterloading techniques are key factors expected to drive market growth
The global brachytherapy market size was USD 404.28 million in 2020 and is expected to register a CAGR of 4.7% during the forecast period. Increasing use of brachytherapy in cancer treatment, rapid advancements in afterloading machines and subsequent improvements in quality of treatments, and expanding use of brachytherapy as radical or palliative treatment are some key factors expected to drive market revenue growth over the forecast period. Development of remote afterloading techniques have significantly reduced radiation exposure risks and advancements in imaging modalities have increased positional accuracy and optimized dose distribution, and this has contributed significantly to revenue growth of the market over the recent past and the trend is expected to continue.
Brachytherapy is a radiotherapy technique in which radioactive devices are implanted near tumor sites to safely delivery high doses of radiation to eliminate and shrink malignant tumors while simultaneously preventing damage to surrounding tissues. Since its development, brachytherapy has revolutionized the treatment approaches for breast, cervical, and prostate cancer. Brachytherapy is also a viable therapeutic option for occult early-stage lung cancer where surgery cannot be performed due to certain reasons. Major treatment sites for brachytherapy include cancers of uterine cervix, prostate, endometrium, eye, and head and neck. Commonly used techniques for brachytherapy include interstitial brachytherapy, intracavity brachytherapy, and episcleral brachytherapy. Over the recent past, brachytherapy has undergone remarkable technological advancement which has led to expansion of its potential application to a variety of clinical indications. Increasing investment to accelerate research and development activities in radiology is also expected to further contribute to revenue growth of the market.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/2640
However, long-term adverse effects associated with brachytherapy such as erectile dysfunction, bladder inflammation, leakage of urine, and nausea and fatigue can limit preference for brachytherapy for treatment of cancer. In addition, increasing concerns regarding radiation leakage in off-target sites can also potentially hamper use of brachytherapy and can potentially restrain market revenue growth to a certain extent over the forecast period.
Some Key Highlights From the Report:
- High-dose rate brachytherapy is widely used in treatment of prostate cancer, breast cancer, and skin cancer, among others owing to excellent ability to deliver high dose radiation directly to target tissue without causing radiation exposure to surrounding tissue. High dose rate brachytherapy is performed as an outpatient procedure and is cost-effective, convenient, and does not require hospital admission and these key factors are expected to contribute to revenue growth of this segment.
- Brachytherapy applicators segment is expected to register significant revenue growth over the forecast period owing to increasing availability of wide range of applicators that are designed to deliver precise doses of radiation and increasing use of applicators to guide radiation dose administration during treatment of gynecological cancers.
- Prostate cancer segment is expected to account for a significantly large revenue share over the forecast period attributable to high prevalence of prostate cancer worldwide, increasing use of HDR-BT to treat high-risk and non-metastatic prostate cancer, and growing awareness regarding benefits of brachytherapy in treatment of prostate cancer.
- Hospital segment revenue is expected to expand significantly attributable to availability advanced and high-end radiology equipment, presence of skilled radiologists, development of robust cancer care hospitals, increased access to state-of-the-art medical facilities, and implementation of favorable reimbursement policies.
- Asia Pacific is expected to register a steady revenue CAGR over the forecast period attributable to increasing prevalence of cancer in APAC countries such as India and China, rising investment to accelerate development of better healthcare facilities, growing preference for brachytherapy due to rising awareness regarding benefits of early treatment of cancer, and accessibility to advanced and next-gen cancer treatments.
- Major companies in the market report include Varian Medical Systems, Becton, Dickinson & Company, Elekta AB, Boston Scientific Corporation, CR Bard Inc., GE Healthcare, Carl Zeiss Meditec AG, Argon Medical Devices Inc., and Panacea Medical Technologies.
- In October 2021, Edinburgh Cancer Center announced that it would be offering high dose rate brachytherapy for treatment of aggressive prostate cancer. It is the first cancer care center in Scotland to offer HDR-BT for treating prostate cancer.
To know more about the report @ https://www.reportsanddata.com/report-detail/brachytherapy-market
For the purpose of this report, Reports and Data has segmented the brachytherapy market based on type, products, application, end use, and region:
Type Outlook (Revenue, USD Million; 2018-2028)
- High Dose Rate (HDR) Brachytherapy
- Low Dose Rate (LDR) Brachytherapy
Products Outlook (Revenue, USD Million; 2018-2028)
- Brachytherapy After Loader
- Brachytherapy Applicators
- Intraluminal Applicators
- Interstitial Applicators
- Intraoperative and Surface Applicators
- Brachytherapy Software
Application Outlook (Revenue, USD Million; 2018-2028)
- Prostate Cancer
- Gynecological Cancer
- Cervical Cancer
- Endometrial Cancer
- Vaginal Cancer
- Breast Cancer
- Other Cancers
End-Use Outlook (Revenue, USD Million; 2018-2028)
- Hospitals
- Oncology Treatment Centers
- Others
Buy Premium Research Report @ https://www.reportsanddata.com/checkout-form/2640
Regional Outlook (Revenue, USD Million; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/2640
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Acidophilus Probiotic Market Size, Share & Analysis, By Type (Human Probiotics, Animal Probiotics), By Application (Probiotic Foods & Beverages, Probiotic Dietary Supplements, Animal Feed Probiotics), And By Region, Forecasts To 2027
Optometry Equipment Market Analysis By Type (General Examination Products, Retina And Glaucoma Examination Products, Cornea And Cataract Examination Products, Others) By Application (Hospital, Clinic, Others) And By Region Forecast To 2028
Blood Collection Market Size, Share and Industry Analysis By Product (Blood Collection Tubes, Needles & Syringes, Blood Bags, Blood Collection Systems/Monitors and Lancets), By Method (Manual, and Automated), By Application, By End Use, and By Region Forecast to 2028
Surgical Imaging Market By Technology (Image Intensifier C-Arms, Flat-Panel Detector C-Arms), By Application (Orthopedic & Trauma Surgeries, Cardiovascular Surgeries, and Others), By End-use (Hospitals, Ambulatory Surgical Centers, Academic & Research Institutes), and By Region Forecasts To 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-brachytherapy-market